{"title":"Part II: The Legislative Environment of Pharmaceutical Marketing","authors":"Mickey C. Smith","doi":"10.3109/J058V18N01_03","DOIUrl":null,"url":null,"abstract":"ABSTRACTIn Part II, the editor looks at the Kefauver, Nelson, and Kennedy drug industry hearings and the legislation resulting from the hearigs. Portions of the hearings are prestented, along with analysis and discussion of the ultimate effects of the hearings on the pharmaceutical industry and pharmacy. The editor then offers a defense of pharmaceutical marketing and some possibilities for its future.","PeriodicalId":16734,"journal":{"name":"Journal of Pharmaceutical Marketing & Management","volume":"63 1","pages":"17-89"},"PeriodicalIF":0.0000,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Marketing & Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3109/J058V18N01_03","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
ABSTRACTIn Part II, the editor looks at the Kefauver, Nelson, and Kennedy drug industry hearings and the legislation resulting from the hearigs. Portions of the hearings are prestented, along with analysis and discussion of the ultimate effects of the hearings on the pharmaceutical industry and pharmacy. The editor then offers a defense of pharmaceutical marketing and some possibilities for its future.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
